NY A 523
in committeeDirects the department of health to create a prescription drug inventory database
New York · 2025-2026 Regular Session · lower
Quick answers
Did NY A 523 pass?
Not yet. NY A 523 is in committee as of 2026-01-15 and has not come to a final vote. Latest recorded action (2026-01-15): ENACTING CLAUSE STRICKEN
What is NY A 523 about?
Directs the department of health to create a prescription drug inventory database that contains a list of all drugs designated as being currently in shortage by the federal food and drug administration's drug shortages database, and a list of pharmacies in the state where each such drug is currently in stock.
Who sponsors NY A 523?
Phil Steck is the primary sponsor of NY A 523.
Description
Directs the department of health to create a prescription drug inventory database that contains a list of all drugs designated as being currently in shortage by the federal food and drug administration's drug shortages database, and a list of pharmacies in the state where each such drug is currently in stock.
- Introduced
- —
- Latest action
- 2026-01-15 — ENACTING CLAUSE STRICKEN
- Bill type
- bill
- Last updated
- —
Sponsors
- Phil Steckprimary
Committees
Not provided by source.
Action timeline
2025-01-08
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
2026-01-15
ENACTING CLAUSE STRICKEN
Versions
- A523Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: A 8039not in this corpus
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 523. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.